Intravascular coagulation, thrombosis, and fibrin deposition often produce tissue damage in allogeneic inflammatory reactions such as allograft rejection. The mechanisms which initiate blood clotting in these reactions are poorly understood. We find that allogeneic stimulation of human leukocytes in vitro increases production and expression of tissue thromboplastin-like activity. In our experiments mixed leukocyte cultures (MLC) of cells from allogeneic (unrelated) donors produced and expressed more procoagulant activity than control cultures of cells from each donor alone. After 7 days, allogeneic MLC had 5-to 50-fold more total procoagulant activity than controls, as shown by assaying lysed whole cultures. Additionally, allogeneic MLC had 8-to 240-fold more procoagulant activity expressed on leukocyte surfaces and in culture supernates than controls after 7 days, as shown by assaying intact whole cultures and cell-free supernates. These increases were largely accounted for by gains in the amounts of procoagulant activity produced and expressed per cell in MLC as compared to controls. Controls and MLC produced and expressed considerable amounts of procoagulant activity during the 1st day of culture, and there were no differential effects of allogeneic stimulation on day 1. However, after day 1, the total amount of procoagulant activity produced and the amount expressed declined steadily in controls, nearly reaching preculture levels by day 7. In contrast, the total amount of procoagulant activity in […] donor produced and expressed more activity than controls (at least 9-and 35-fold more, respectively). Thus, increases of procoagulant activity production and expression were found only in MLC of genetically dissimilar cells. Therefore, these increases must have resulted from allogeneic stimulation.
A B S T R A C T Intravascular coagulation, thrombosis, and fibrin deposition often produce tissue damage in allogeneic inflammatory reactions such as allograft rejection. The mechanisms which initiate blood clotting in these reactions are poorly understood. We find that allogeneic stimulation of human leukocytes in vitro increases protluction and expression of tissue thromboplastin-like activity. In our experiments mixed leukocyte cultures (MLC) of cells from allogeneic (unrelated) donors produced and expressed more procoagulant activity than control cultures of cells from each donor alone. After 7 days, allogeneic MLC had 5-to 50-fold more total procoagulant activity than controls, as shown by assaying lysed whole cultures. Additionally, allogeneic MLC had 8-to 240-fold more procoagulant activity expressed on leukocyte surfaces and in culture supernates than controls after 7 days, as shown by assaying intact whole cultures and cell-free supernates. These increases were largely accounted for by gains in the amounts of procoagulant activity produced and expressed per cell in MLC as compared to controls. Controls and MLC produced and expressed considerable amounts of procoagulant activity during the 1st day of culture, and there were no differential effects of allogeneic stimulation on day 1. However, after day 1, the total amount of procoagulant activity produced and the amount expressed declined steadily in controls, nearly reaching preculture levels by day 7. In contrast, the total amount of procoagulant activity in allogeneic MLC remained high, and the amount of activity expressed on cell surfaces and in supernates increased severalfold by day 7. MLC of syngeneic (identical twin) cells produced and expressed the same amount of activity as controls over a 7-day period, whereas MLC of cells from each twin and an allogeneic INTRODUCTION Tissue thromboplastin is a procoagulant lipoprotein which activates Factor VII (2) and thereby initiates coagulation through the extrinsic clotting system. Mechanisms responsible for stimulating cellular production of tissue thromboplastin activity may be of considerable importance in producing thrombosis and inflammation. Tissue thromboplastin apoprotein has been demonstrated on the surfaces of a variety of cell types by an immunoperoxidase technique (3) . Lipoproteins with tissue thromboplastin activity can be extracted from organs such as lung, placenta, and brain, but only very small amounts of this activity have been demonstrated in freshly isolated cells.
Leukocytes participate in inflammatory reactions and there is evidence indicating that these cells can activate coagulation proteins. Freshly isolated normal human leukocytes have little or no procoagulant activity (4) . However, leukocytes incubated in the presence of plasma, serum, endotoxin, phytohemagglutinin, or purified protein derivative are stimulated to produce large amounts of tissue thromboplastin-like activity (5) (6) (7) (8) (9) . Leukocytes with this activity are capable of initiating disseminated intravascular coagulation, thrombosis, and Shwartzman-like reactions when infused into experimental animals. In addition, endotoxin injections have been found to stimulate in vivo production of procoagulant activity by leukocytes in animals undergoing classical Shwartzman reactions (10, 11) .
Experimental and clinical evidence indicates that immunologic diseases such as lupus erythematosus, rheumatoid arthritis, and allograft rejection resemble the classical Shwartzman reaction in that considerable tissue damage may be produced by thrombosis and(or) fibrin deposition (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) . However, very little is known about mechanisms which initiate blood coagulation in these immunologic diseases (25) . Recently, we have shown that incubation of human leukocytes with IgG of at least three of the four subclasses enhances de novo production of a tissue thromboplastin-like activity by these cells, and soluble antigen-antibody complexes are especially effective (4) . In the present study, we show that in vitro allogeneic stimulation of human leukocytes increases production and expression of tissue thromboplastin-like procoagulant activity.
METHODS
Isolation and culture of leukocytes. Human venous blood was collected in evacuated 10-ml glass tubes (Becton, Dickinson & Co., Rutherford, N. J.) containing 15 mg of potassium EDTA or in a sterile syringe containing heparin (2 U/ml). These two methods gave similar results. Leukocytes were isolated by centrifugation of washed buffy coats on FicollHypaque (Ficoll, Sigma Chemical Co., St. Louis, Mo.; Hypaque, Winthrop Laboratories, New York) gradients as previously described (4) . The resultant leukocyte population contained a mean of 90% lymphocytes and 10% monocytes as well as small numbers of erythrocytes and platelets.
Isolated leukocytes were cultured in 5-ml polypropylene tubes using RPMI-1640 tissue culture medium containing 25 mM Hepes buffer, 17% human AB serum, and 2 mM L-glutamine. Serum was prepared from whole blood clotted for 4 h at 37°C. Serum was then heated at 560C for 45 min to inactivate complement and thrombin. In some experiments serum was also absorbed three to four times with aluminum hydroxide as described elsewhere (26) eter. Leukocyte viabilities were assayed by the method of trypan blue exclusion (27) .
Sterile techniques. Sterile reagents and plastieware were used in all experiments. Complete culture medium was sterilized by filtration through 0.22-,uM filters (Millipore Corp., Bedford, Mass.) immediately before use. Pipetting procedures were carried out in a sterile tissue culture hood. After culture, leukocyte preparations were examined microscopically to facilitate detection of possible contamination with bacteria and fungi. Contamination was very rare, and only results with uncontaminated preparations are reported. As an additional check for sterility, cultured cells were transferred to tubes containing trypticase soybroth and incubated for 72 h. Bacterial growth was not seen in these tubes.
One-stage assay of procoagulant activity. 0.1 ml of leukocyte culture was placed into a 12 x 75-mm glass tube in a 37°C water bath. 0.1 ml of 0.025 M CaCl2, followed by 0.1 ml of citrated human plasma was added, and the clotting times were then determined. Substrate plasma was obtained from normal human subjects and from patients congenitally deficient in Factor VIII or Factor IX. Congenitally deficient plasmas with <1I% of normal Factor V, VII, or X activity were obtained commercially (George-King Biomedical, Inc., Salem. N. H.). Three different Factor VII-deficient plasmas (lots GK 702-629; Gk 703-714; GK 701-522) gave similar results in our experiments.
Conversion of clotting time to relative procoagulant activity: calculation ofthromboplastin units. The amount ofprocoagulant activity present in each MLC was compared with the amounts in controls from the same experiment. (Controls contained cells from the two donors cultured individually.) This comparison was made by first converting clotting times to percent activity using a calibration curve and then to relative procoagulant activity, as described below.
Calibration curves were prepared by assaying the procoagulant activity of doubling dilutions of MLC lysed by freezethawing on day 6 or 7. Dilution was plotted against clotting time on log-log paper. The clotting time obtained with the undiluted preparation was assigned a procoagulant activity value of 100%, a 1: 1 dilution a value of50% and so on. Analysis of 18 MLC harvested on days 6 and 7 showed a logarithmic relationship between clotting time and procoagulant activity throughout the range ofclotting times encountered (48-300 s).
Individual curves were derived for most experiments. In a few experiments the median slope (-0.196 
RESULTS
Demonstration that increased amounts of procoagulant activity are expressed on cell surfaces and in supernates of MLC. In order to measure the amounts of procoagulant activity of cultured leukocytes that might be considered as physiologically "expressed", we assayed intact whole cultures containing viable cells. This measurement included procoagulant activity bound to leukocyte surfaces and activity released into supernatants. Leukocytes did not express measurable procoagulant activity before incubation, (i.e., the amount ofactivity present was the same as with culture medium alone). However, after one day of culture considerable amounts ofactivity were expressed in MLC as well as in individual donor controls, as indicated by results on day 1 (Fig. 1A) . During the next few days, the amount of expressed activity diminished steadily in controls. In contrast, expressed activity in MLC remained at high levels and increased an additional severalfold by day 4-7. After this increase, MLC consistently showed greater amounts of expressed activity than controls harvested even at their peak activity (day 1).
To measure the amounts of expressed procoagulant activity released from cells, cell-free culture supernates were assayed. Very little activity was detected in the supernates of controls throughout the 7 days of culture. Although very little activity was found in the supernates of MLC before day 3, supernatant activity increased considerably in MLC after 3-7 days. Consequently, after 7 days ofculture, supernates from MLC showed greater procoagulant activity than controls. However, the amounts of activity found in supernates of MLC were small relative to the total amount of expressed activity in whole intact cultures (Table I) . Since the difference between the amount of total expressed activity and the amount in the supernate represented leukocyte surface activity, expressed activity was mostly surface bound.
Demonstration that increased amounts of procoagulant activity are present intracellularly in MLC. To measure intracellular procoagulant activity we compared results with whole cultures assayed intact (unlysed) and cultures which were lysed at the time of harvest. Assays of lysed cultures gave the total amounts of procoagulant activity produced (Fig. 1B) . The in- creased activity seen with lysed as compared to intact preparations was considered to represent intracellular activity. Leukocytes did not show any measurable intracellular procoagulant activity before incubation. After the 1st day of culture, large amounts of intracellular activity were found in MLC and controls, as indicated by results on day 1 (Fig. 1) . Occasionally, the intracellular procoagulant activities of MLC and controls were significantly different on day 1, but these differences were relatively small (median <2.5-fold); either MLC or control preparations gave greater activity in various experiments. After day 1, intracellular MLC and individually cultured controls were harvested after 1-7 days. Results compiled from a number of experiments using a panel of allogeneic leukocyte donors are shown. The procoagulant activity of each MLC was compared to the two individually cultured controls from the same experiment and day. Ratios of MLC/control activity, i.e., "relative procoagulant activities" of MLC, were calculated as described in Methods. * Often the two cultures for each MLC produced slightly different amounts of activity. Therefore, MLC activity was calculated relative to both controls. "Hi" designates the MLC/control ratio using the control producing the greater amount of procoagulant activity. "Lo" is the MLC/control ratio using the control producing the lesser amount.
activity in controls diminished steadily, nearly reaching preculture levels within 4-7 days. In contrast, intracellular activity in MLC was sustained at high levels throughout the 7-day period of observation. Consequently, MLC had greater amounts of intracellular activity than controls by day 7.
Ratnge of procoagulant activity increases in MLC. To examine the range of procoagulant activity increases in response to allogeneic stimulation, cells from 16 unrelated donors were tested in MLC. To assure a broad survey, cells from each of these donors were used in two allogeneic combinations at most. After only 1 day of culture there was no consistent difference in the amounts of expressed activity in MLC and controls (Table II , intact cells). After 6 days of culture, all 19 initact MLC expressed much more procoagulant activity than controls, and by day 7 these differences were even more pronounced. Similarly, lysed MLC showed the same amounts of activity as controls on day 1, indicating that the total activities (including intracellular and expressed) were the same in these preparations. However, by day 7 lysed MLC showed greater amounts of procoagulant activity than controls in all of the nine combinations tested (Table II, lysed cells) . Thus, the amounts of expressed and total procoagulant activity were significantly greater in MLC than controls by day 7 in every allogeneic combination tested.
Demonstrationi that procoagulatnt activity production1 is stimulated by (illogetneic interactiotns: absence of stimulation with idlentical tWin1.s. To demonstrate that increases of procoagulant activity in MLC result from allogeneic stimulation rather than from other factors, the amounts of activity produced and expressed in MLC of cells from syngeneic (identical) twins were compared with the amounts in controls and allogeneic (unrelated donor) MLC. Syngeneic MLC were found to have the same amounts of procoagulant activity as individually cultured controls on days 1-7. In contrast, allogeneic MLC containing leukocytes from either twin and an unrelated donor had far greater amounts of activity than controls by day 7 (Fig. 2 twins. Since increases of activity were only seen in MLC of genetically dissimilar cells, nonspecific cellular interactions and effects of possible contaminants such as endotoxin cannot account for the increases observed. Rather, allogeneic stimulation must have triggered these increases. Demonstration that increased amounts of procoagulant activity are produced and expressed per cell in allogeneic MLC. To determine the amounts of procoagulant activity produced and expressed per cell in MLC and controls, leukocyte counts and viabilities in culture were monitored throughout the period of observation. Viability was found to be the same in all preparations through day 7 (99-100%). However, somewhat higher leukocyte concentrations were found in MLC than in controls by day [5] [6] [7] (median: 1.25-fold higher on day 7). Differences of leukocyte concentration were quite small relative to differences of procoagulant activity. Consequently, there was much more procoagulant activity produced and expressed per cell in MLC than in controls (Table III ). An additional demonstration ofthis effect was provided by a study of MLC started with 50% fewer cells than controls. After (4) . After day 1 activity in control cultures diminished steadily. In contrast, in MLC, intracellular activity was sustained throughout the 7-day period of observation. Furthermore, expressed activity increased an additional severalfold between days 4 and 7, reaching levels greater than in controls even at peak activity (day 1). This increase was mostly due to augmentation of cell surface activity, but some additional activity was also released into the supernates. By day 7, the amounts of intracellular, cell surface, and supernatant activities were all greater in the MLC than in controls.
Other investigators have recently reported that they were unable to find increases in procoagulant activity in MLC assayed after 1, 2, and 3 days of culture (28) . Our findings are in agreement with these workers in that the increases in procoagulant activity of MLC over controls were not seen after short-term culture. However, our experiments show clearly that after 7 days of culture, activity is very significantly increased in MLC.
These findings may be of importance in several situations. The MLC has been widely used as an in vitro model of histocompatibility and as a tool for defining leukocyte histocompatibility antigens. The biologic response normally assayed has been one of cell growth measured as [3H]thymidine incorporation into cultured cells (29) . However, lymphokine production assayed as lymphocytoxin or migration inhibitory factor production have also been shown to be useful in this regard (30, 31) . Our findings indicate that production and expression of tissue thromboplastin-like activity is yet another part of the MLC reaction and this activity may play a role in the pathophysiology of allograft rejection (see below). It is therefore possible that measurement oftissue thromboplastic-like activity in allogeneic leukocyte cultures will prove to be of value in studying histocompatibility.
Intravascular coagulation and/or thrombosis appear to be pathogenetic in allogeneic tissue reactions such as allograft rejection, graft-vs.-host and host-vs.-graft phenomena (18, 24, 32, 33) . The mechanisms which initiate clotting in these reactions are poorly understood. Tissue thromboplastin is a potent initiator of the coagulation sequence and it is reasonable to propose that production of tissue thromboplastin by allogeneically stimulated leukocytes may contribute to tissue damage in these inflammatory reactions.
